Arkolith/Insider Trading/STSA/Form 4

Commodore Capital LP

10% OwnerSatsuma Pharmaceuticals, Inc. (STSA) · full profile →Form 4 · filed Oct 29, 2021
Net Buying
Open-Market Buys
$299K
Open-Market Sells
$0
Net Open-Market Flow
$299K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Oct 28, 2021Buy(P)15K$5.55$84K3.6M
Oct 27, 2021Buy(P)40K$5.45$216K3.6M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000905718-21-001408) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML